DAVA HOFFMAN: Open Payments
NPI 1760030084 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 35 payments from 16 companies in 2025. Trend: 2023 $32 · 2024 $124 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $175 |
| Novo Nordisk Inc | 6 | $133 |
| Philips North America LLC | 3 | $76 |
| Viatris Specialty LLC | 2 | $43 |
| Exact Sciences Corporation | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Verona Pharma, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: QULIPTA, Ozempic, Encore, YUPELRI, Cologuard Collection Kit, Wegovy, Kerendia, GEMTESA.
Industry payments across MO — which companies pay providers there.
